• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对新冠疫苗接种的体液和细胞免疫反应表明,体弱人群接种疫苗后需要进行检测。

Humoral and Cellular Responses to COVID-19 Vaccination Indicate the Need for Post-Vaccination Testing in Frail Population.

作者信息

Witkowski Wojciech, Gerlo Sarah, De Smet Evelien, Wejda Magdalena, Acar Delphine, Callens Steven, Heytens Stefan, Padalko Elizaveta, Vercruysse Hanne, Cools Piet, Vandekerckhove Linos

机构信息

HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, 9000 Ghent, Belgium.

Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.

出版信息

Vaccines (Basel). 2022 Feb 8;10(2):260. doi: 10.3390/vaccines10020260.

DOI:10.3390/vaccines10020260
PMID:35214717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8875521/
Abstract

Despite the high efficacy of the BNT162b2 vaccine in the general population, data on its immunogenicity among frail elderly individuals are limited. Recently, levels of anti-SARS-CoV-2 spike IgG antibodies and serum neutralization titers were confirmed as good immune markers of protection against the virus, with evidence showing a reverse correlation between these two parameters and susceptibility to infection. Here we analyzed sera from 138 nursing home residents (median age of 88.9 years) and 312 nursing home staff (median age of 50.7 years) to determine the humoral response to two doses of the BNT162b2 vaccine, and found markedly decreased serum anti-spike antibody levels and neutralization titers in the nursing home resident (NHR) group, with over 11% non-responders compared to only 1.3% among the controls. Moreover, three months post-vaccination, a significant decrease in antibody titers was observed in COVID-19-naive nursing home residents. Subsequent flow cytometry and interferon gamma secretion analyses indicated that antibody non-responders among NHRs also failed to mount cellular responses. The presented data emphasize that additional measures are needed in the population of frail elderly individuals. Given the high proportion of non-responders among NHRs, continued monitoring should be considered in this group.

摘要

尽管BNT162b2疫苗在普通人群中具有高效性,但关于其在体弱老年人中的免疫原性数据有限。最近,抗SARS-CoV-2刺突IgG抗体水平和血清中和滴度被确认为针对该病毒的良好免疫保护标志物,有证据表明这两个参数与感染易感性呈负相关。在此,我们分析了138名养老院居民(中位年龄88.9岁)和312名养老院工作人员(中位年龄50.7岁)的血清,以确定对两剂BNT162b2疫苗的体液反应,发现养老院居民(NHR)组的血清抗刺突抗体水平和中和滴度明显降低,无反应者超过11%,而对照组仅为1.3%。此外,在接种疫苗三个月后,未感染过COVID-19的养老院居民的抗体滴度显著下降。随后的流式细胞术和干扰素γ分泌分析表明,NHR中的抗体无反应者也未能产生细胞反应。所呈现的数据强调,体弱老年人需要采取额外措施。鉴于NHR中无反应者比例较高,应考虑对该群体进行持续监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade9/8875521/0977edd30b05/vaccines-10-00260-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade9/8875521/702c800ded0c/vaccines-10-00260-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade9/8875521/227af960e646/vaccines-10-00260-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade9/8875521/5acab79a2c20/vaccines-10-00260-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade9/8875521/0977edd30b05/vaccines-10-00260-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade9/8875521/702c800ded0c/vaccines-10-00260-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade9/8875521/227af960e646/vaccines-10-00260-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade9/8875521/5acab79a2c20/vaccines-10-00260-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ade9/8875521/0977edd30b05/vaccines-10-00260-g004.jpg

相似文献

1
Humoral and Cellular Responses to COVID-19 Vaccination Indicate the Need for Post-Vaccination Testing in Frail Population.对新冠疫苗接种的体液和细胞免疫反应表明,体弱人群接种疫苗后需要进行检测。
Vaccines (Basel). 2022 Feb 8;10(2):260. doi: 10.3390/vaccines10020260.
2
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.在 COVID-19 疫苗接种运动初期,比利时养老院居民和工作人员中 SARS-CoV-2 抗体的流行情况。
Eur J Gen Pract. 2023 Dec;29(2):2149732. doi: 10.1080/13814788.2022.2149732. Epub 2022 Nov 28.
3
Previous SARS-CoV-2 Infection, Age, and Frailty Are Associated With 6-Month Vaccine-Induced Anti-Spike Antibody Titer in Nursing Home Residents.先前的 SARS-CoV-2 感染、年龄和虚弱与养老院居民 6 个月疫苗诱导的抗刺突抗体滴度有关。
J Am Med Dir Assoc. 2022 Mar;23(3):434-439. doi: 10.1016/j.jamda.2021.12.001. Epub 2022 Jan 11.
4
Follow-Up of SARS-CoV-2 Antibody Levels in Belgian Nursing Home Residents and Staff Two, Four and Six Months after Primary Course BNT162b2 Vaccination.比利时养老院居民和工作人员在初次接种BNT162b2疫苗后2个月、4个月和6个月时的SARS-CoV-2抗体水平随访
Vaccines (Basel). 2024 Aug 22;12(8):951. doi: 10.3390/vaccines12080951.
5
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study.BNT162b2 或 ChAdOx1 nCoV-19 疫苗单剂接种后在居住护理院居民和工作人员中的体液和细胞免疫应答特征(VIVALDI):一项观察性研究。
Lancet Healthy Longev. 2021 Sep;2(9):e544-e553. doi: 10.1016/S2666-7568(21)00168-9. Epub 2021 Aug 19.
6
T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.养老院居民中初次接种和加强接种 SARS-CoV-2 信使 RNA 疫苗后的 T 细胞介导的反应。
J Am Med Dir Assoc. 2023 Feb;24(2):140-147.e2. doi: 10.1016/j.jamda.2022.11.024. Epub 2022 Dec 7.
7
Low humoral immune response to the BNT162b2 vaccine against COVID-19 in nursing home residents undergoing hemodialysis: a case-control observational study.养老院中接受血液透析的居民对新冠病毒疫苗BNT162b2的体液免疫反应较低:一项病例对照观察性研究。
Ren Replace Ther. 2022;8(1):8. doi: 10.1186/s41100-022-00397-5. Epub 2022 Mar 16.
8
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.真实世界中衰弱老年人接受延长间隔和异源 COVID-19 mRNA 疫苗接种后的血清学反应(UNCoVER):一项前瞻性观察队列研究的中期报告。
Lancet Healthy Longev. 2022 Mar;3(3):e166-e175. doi: 10.1016/S2666-7568(22)00012-5. Epub 2022 Feb 23.
9
B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.科维希德® COVID-19 疫苗在养老院居民中引发的 B 细胞和 T 细胞免疫应答。
Clin Microbiol Infect. 2021 Nov;27(11):1672-1677. doi: 10.1016/j.cmi.2021.06.013. Epub 2021 Jun 24.
10
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.第三剂 COVID-19 mRNA 疫苗缩小了初入养老院居民与健康成年人之间免疫反应的差距。
Vaccine. 2023 Apr 24;41(17):2829-2836. doi: 10.1016/j.vaccine.2023.03.047. Epub 2023 Mar 27.

引用本文的文献

1
Dynamics of SARS-CoV-2 IgG in Nursing Home Residents in Belgium Throughout Three BNT162b2 Vaccination Rounds: 19-Month Follow-Up.比利时养老院居民在三轮BNT162b2疫苗接种期间的新冠病毒IgG动态:19个月随访
Vaccines (Basel). 2025 Apr 15;13(4):409. doi: 10.3390/vaccines13040409.
2
Follow-Up of SARS-CoV-2 Antibody Levels in Belgian Nursing Home Residents and Staff Two, Four and Six Months after Primary Course BNT162b2 Vaccination.比利时养老院居民和工作人员在初次接种BNT162b2疫苗后2个月、4个月和6个月时的SARS-CoV-2抗体水平随访
Vaccines (Basel). 2024 Aug 22;12(8):951. doi: 10.3390/vaccines12080951.
3
Cytokine profile of anti-spike CD4T cells predicts humoral and CD8T cell responses after anti-SARS-CoV-2 mRNA vaccination.

本文引用的文献

1
COVID-19 Vaccinations in Nursing Home Residents and Staff Give Robust Protection, Though Breakthrough Infections Still Possible.养老院居民和工作人员接种新冠疫苗可提供强有力的保护,不过仍有可能出现突破性感染。
JAMA Health Forum. 2021 Apr 1;2(4):e211195. doi: 10.1001/jamahealthforum.2021.1195.
2
Protection against Covid-19 by BNT162b2 Booster across Age Groups.辉瑞-BioNTech 疫苗加强针在各年龄段对预防新冠病毒的保护作用
N Engl J Med. 2021 Dec 23;385(26):2421-2430. doi: 10.1056/NEJMoa2115926. Epub 2021 Dec 8.
3
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
抗刺突蛋白CD4 T细胞的细胞因子谱可预测抗SARS-CoV-2 mRNA疫苗接种后的体液和CD8 T细胞反应。
iScience. 2024 Jul 2;27(8):110441. doi: 10.1016/j.isci.2024.110441. eCollection 2024 Aug 16.
4
Epidemiology of COVID-19 outbreaks in aged care facilities during postvaccine period: a systematic review and meta-analysis.疫苗接种后老年护理机构中 COVID-19 疫情的流行病学:系统评价和荟萃分析。
BMJ Open. 2024 Mar 14;14(3):e073555. doi: 10.1136/bmjopen-2023-073555.
5
Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted.在 SARS-CoV-2 抗体发现管道中集成基于人工智能的表位预测:需要谨慎。
EBioMedicine. 2024 Feb;100:104960. doi: 10.1016/j.ebiom.2023.104960. Epub 2024 Jan 16.
6
Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study.老年人接种新冠病毒疫苗后抗体反应的潜在决定因素:多廷赫姆队列研究
Immun Ageing. 2023 Oct 25;20(1):57. doi: 10.1186/s12979-023-00382-4.
7
No Significant Association between 25-OH Vitamin D Status and SARS-CoV-2 Antibody Response after COVID-19 Vaccination in Nursing Home Residents and Staff.养老院居民和工作人员接种新冠疫苗后,25-羟基维生素D状态与新冠病毒抗体反应之间无显著关联。
Vaccines (Basel). 2023 Aug 8;11(8):1343. doi: 10.3390/vaccines11081343.
8
Evolution of antibody titers after two doses of mRNA Pfizer-BioNTech vaccine and effect of the third dose in nursing home residents.两剂 mRNA 辉瑞-生物科技疫苗接种后的抗体效价演变及第三剂在养老院居民中的效果。
PLoS One. 2023 Mar 8;18(3):e0282388. doi: 10.1371/journal.pone.0282388. eCollection 2023.
9
Vaccines for the Prevention of Coronavirus Disease 2019 in Older Adults.用于预防老年人 2019 冠状病毒病的疫苗。
Infect Dis Clin North Am. 2023 Mar;37(1):27-45. doi: 10.1016/j.idc.2022.11.002. Epub 2022 Nov 4.
10
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.在 COVID-19 疫苗接种运动初期,比利时养老院居民和工作人员中 SARS-CoV-2 抗体的流行情况。
Eur J Gen Pract. 2023 Dec;29(2):2149732. doi: 10.1080/13814788.2022.2149732. Epub 2022 Nov 28.
mRNA-1273 新冠疫苗有效性临床试验的免疫相关性分析。
Science. 2022 Jan 7;375(6576):43-50. doi: 10.1126/science.abm3425. Epub 2021 Nov 23.
4
Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents.在养老院居民中使用 Comirnaty® COVID-19 疫苗全剂量接种后对 SARS-CoV-2 的免疫应答。
Clin Microbiol Infect. 2022 Feb;28(2):279-284. doi: 10.1016/j.cmi.2021.09.031. Epub 2021 Oct 5.
5
SARS-CoV-2 infection shortly after BNT162b2 vaccination results in high anti-spike antibody levels in nursing home residents and staff.接种 BNT162b2 疫苗后不久感染 SARS-CoV-2 可使疗养院居民和工作人员的抗刺突抗体水平升高。
Immun Inflamm Dis. 2021 Dec;9(4):1702-1706. doi: 10.1002/iid3.525. Epub 2021 Sep 9.
6
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.新冠疫苗突破性感染在已接种疫苗的医护人员中发生。
N Engl J Med. 2021 Oct 14;385(16):1474-1484. doi: 10.1056/NEJMoa2109072. Epub 2021 Jul 28.
7
Direct and Indirect Effectiveness of mRNA Vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 in Long-Term Care Facilities, Spain.mRNA 疫苗对西班牙长期护理机构中严重急性呼吸综合征冠状病毒 2 有效性的直接和间接影响
Emerg Infect Dis. 2021 Oct;27(10):2595-2603. doi: 10.3201/eid2710.211184. Epub 2021 Jul 27.
8
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.Covid-19 疫苗对 B.1.617.2(德尔塔)变异株的有效性。
N Engl J Med. 2021 Aug 12;385(7):585-594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21.
9
Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort-19 study.养老院居民接种一剂和两剂 BNT162b2 疫苗后的抗体反应:CONsort-19 研究。
Allergy. 2022 Jan;77(1):271-281. doi: 10.1111/all.15007. Epub 2021 Jul 29.
10
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.与年龄相关的对 SARS-CoV-2 疫苗 BNT162b2 的免疫反应异质性。
Nature. 2021 Aug;596(7872):417-422. doi: 10.1038/s41586-021-03739-1. Epub 2021 Jun 30.